LifeMD director granted 85,000 restricted shares

LifeMD, Inc. (LFMD) director John R. Strawn Jr. reported two equity compensation grants of the company’s Common Stock.

Rhea-AI Filing Summary

LifeMD, Inc. (LFMD) director John R. Strawn Jr. reported two equity compensation grants of the company’s Common Stock. On May 4, 2026, he acquired 50,000 restricted shares that, per a footnote, vest immediately. On August 11, 2026, he received an additional 35,000 restricted shares that vest on June 1, 2027. Both awards were granted at a reported price of $0.00 per share, consistent with stock-based compensation rather than open-market purchases. A separate holding entry shows 60,000 shares of Common Stock held indirectly through Strawn Pickens LLP.

Insider Trade Summary

Grant/Award: 85,000 shares

Grant/Award 3 txns

Insider Strawn John R Jr

Role Director

Type	Security	Shares	Price	Value
Grant/Award	Common Stock F2	35,000	$0.00	$0.00
Grant/Award	Common Stock F1	50,000	$0.00	$0.00
holding	Common Stock	--	--	--

Holdings After Transaction: Common Stock — 498,001 shares (Direct); Common Stock — 60,000 shares (Indirect, Strawn Pickens LLP)

Footnotes (2)

1. F1. The grant of restricted shares vests immediately.
2. F2. The grant of restricted shares vests on June 1, 2027.

Key Figures

Restricted shares granted (May 4, 2026): 50,000 shares Restricted shares granted (August 11, 2026): 35,000 shares Grant price per share: $0.00 per share +2 more

5 metrics

Restricted shares granted (May 4, 2026) 50,000 shares Equity compensation award of Common Stock to director John R. Strawn Jr.

Restricted shares granted (August 11, 2026) 35,000 shares Additional equity compensation award of Common Stock to the same director

Grant price per share $0.00 per share Reported for both restricted stock awards as stock-based compensation, not market purchases

Indirect holdings via Strawn Pickens LLP 60,000 shares Common Stock held indirectly as of May 4, 2026

Vesting date of 35,000-share grant June 1, 2027 Future vesting date for the 35,000 restricted shares granted on August 11, 2026

Key Terms

restricted shares, vests immediately, indirect, Common Stock

4 terms

restricted shares financial

"The grant of restricted shares vests immediately."

Restricted shares are company stock that cannot be sold or transferred immediately because they are subject to legal or contractual limits, such as a required holding period or performance conditions. They matter to investors because these locked-up shares can affect a company’s available stock for trading, future dilution, and insider incentives—imagine a gift that can’t be cashed until certain conditions are met, which changes when and how much supply can suddenly enter the market.

vests immediately financial

"The grant of restricted shares vests immediately."

indirect financial

"total_shares_following_transaction":"60000.0000","direct_or_indirect":"I""

Common Stock financial

"security_title":"Common Stock","transaction_date":"2026-08-11""

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did LifeMD (LFMD) disclose for John R. Strawn Jr.?

LifeMD reported that director John R. Strawn Jr. received two grants of Common Stock: 50,000 restricted shares on May 4, 2026 and 35,000 restricted shares on August 11, 2026, both at a reported price of $0.00 per share.

What are the vesting terms of the new LifeMD (LFMD) restricted stock grants?

The 50,000-share restricted stock grant on May 4, 2026 vests immediately. The 35,000-share restricted stock grant on August 11, 2026 vests on June 1, 2027, according to the attached footnotes describing each award’s vesting schedule.

Did John R. Strawn Jr. buy LifeMD (LFMD) shares on the open market?

No. The Form 4 shows equity grants, not market purchases. Both the 50,000-share and 35,000-share transactions are coded as awards at a reported $0.00 per share, indicating stock-based compensation rather than open-market buying.

How many LifeMD (LFMD) shares does John R. Strawn Jr. hold indirectly?

A holding entry shows 60,000 shares of LifeMD Common Stock held indirectly through an entity named Strawn Pickens LLP. This reflects an indirect ownership position separate from the directly held restricted share awards.

Is the LifeMD (LFMD) Form 4 filed under a Rule 10b5-1 trading plan?

No. The filing’s Rule 10b5-1 checkbox is not marked as affirmative, and the footnotes describe the awards simply as grants of restricted shares, with no reference to a pre-arranged trading plan.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Available on EDGAR 08/18/2026 - 04:51 PM Accepted by SEC EDGAR 08/18/2026 - 04:51 PM Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Strawn John R Jr

(Last) (First) (Middle)

C/O LIFEMD, INC.

236 FIFTH AVENUE, 4TH FLOOR

(Street)

NEW YORK NEW YORK 10001

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
LifeMD, Inc. [ LFMD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
05/04/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	05/04/2026		A		50,000(1)	A	$0	463,001	D
Common Stock	08/11/2026		A		35,000(2)	A	$0	498,001	D
Common Stock								60,000	I	Strawn Pickens LLP

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The grant of restricted shares vests immediately.

2. The grant of restricted shares vests on June 1, 2027.

	/s/ John R. Strawn Jr.	08/18/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)